Authors: Bantar, C Nicola, F Canigia, LF Arenoso, HJ Soutric, J Montoto, M Blanco, M Smayevsky, J Jasovich, A

Citation: C. Bantar et al., Rationale for treating community-acquired lower respiratory tract infections with amoxicillin/sulbactam combination through pharmacodynamic analysis in the setting of aminopenicillin-resistant organisms, J CHEMOTHER, 13(4), 2001, pp. 402-406

Authors: Casellas, JM Visser, M Tome, G Cohen, H Soutric, J Arenoso, H

Citation: Jm. Casellas et al., Escherichia coli eradication from the blader urine by amoxicillin-sulbactam. Intrinsic activity of the inhibitor, ENFERM INF, 19(5), 2001, pp. 206-210

Authors: Bantar, C Nicola, F Canigia, LF Arenoso, HJ Soutric, J Montoto, M Blanco, M Smayevsky, J Jasovich, A

Citation: C. Bantar et al., A pharmacodynamic model to support a 12-hour dosing interval for amoxicillin/sulbactam, a novel oral combination, in the treatment of community-acquired lower respiratory tract infections, J CHEMOTHER, 12(3), 2000, pp. 223-227